Cargando…
Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology S...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197398/ https://www.ncbi.nlm.nih.gov/pubmed/34073986 http://dx.doi.org/10.3390/jcm10112278 |
_version_ | 1783706911070224384 |
---|---|
author | Brindisi, Giulia De Vittori, Valentina De Nola, Rosalba Pignataro, Elia Anania, Caterina De Castro, Giovanna Cinicola, Bianca Gori, Alessandra Cicinelli, Ettore Zicari, Anna Maria |
author_facet | Brindisi, Giulia De Vittori, Valentina De Nola, Rosalba Pignataro, Elia Anania, Caterina De Castro, Giovanna Cinicola, Bianca Gori, Alessandra Cicinelli, Ettore Zicari, Anna Maria |
author_sort | Brindisi, Giulia |
collection | PubMed |
description | Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, diagnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple-choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhinitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on-demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on-demand and basal therapy in allergic children during the lockdown. |
format | Online Article Text |
id | pubmed-8197398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81973982021-06-13 Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak Brindisi, Giulia De Vittori, Valentina De Nola, Rosalba Pignataro, Elia Anania, Caterina De Castro, Giovanna Cinicola, Bianca Gori, Alessandra Cicinelli, Ettore Zicari, Anna Maria J Clin Med Article Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, diagnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple-choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhinitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on-demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on-demand and basal therapy in allergic children during the lockdown. MDPI 2021-05-24 /pmc/articles/PMC8197398/ /pubmed/34073986 http://dx.doi.org/10.3390/jcm10112278 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Brindisi, Giulia De Vittori, Valentina De Nola, Rosalba Pignataro, Elia Anania, Caterina De Castro, Giovanna Cinicola, Bianca Gori, Alessandra Cicinelli, Ettore Zicari, Anna Maria Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title | Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title_full | Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title_fullStr | Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title_full_unstemmed | Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title_short | Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak |
title_sort | updates on children with allergic rhinitis and asthma during the covid-19 outbreak |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197398/ https://www.ncbi.nlm.nih.gov/pubmed/34073986 http://dx.doi.org/10.3390/jcm10112278 |
work_keys_str_mv | AT brindisigiulia updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT devittorivalentina updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT denolarosalba updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT pignataroelia updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT ananiacaterina updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT decastrogiovanna updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT cinicolabianca updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT gorialessandra updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT cicinelliettore updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak AT zicariannamaria updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak |